- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07669350
Effect of Aquatic Therapy Program on Balance in Children With Spastic Diplegic Cerebral Palsy
20. juni 2026 opdateret af: Ibrahim Ahmed Ibrahim Abu Ella, Delta University for Science and Technology
- Evaluate the effect of a structured aquatic therapy programme on static balance in children with spastic diplegic cerebral palsy.
- Assess the effect of the same programme on dynamic balance in this patient population.
- Compare balance outcomes between children receiving aquatic therapy and those receiving conventional land-based physiotherapy.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Cerebral palsy (CP) is the most common cause of permanent motor disability in childhood, with spastic diplegia being the most prevalent subtype, characterized by bilateral lower limb spasticity, impaired postural control, and significantly compromised balance - deficits that restrict functional mobility and participation in daily activities.
These balance impairments arise from disrupted selective motor control, abnormal muscle tone, reduced proprioceptive integration, and impaired neuromuscular coordination, and represent a central therapeutic target in paediatric rehabilitation.
Aquatic therapy exploits the physical properties of water - buoyancy, hydrostatic pressure, warmth, and viscosity - to reduce spasticity, facilitate movement, and promote motor learning in a safe environment, with meta-analytic evidence confirming significant improvements in gross motor function compared to land-based approaches.
However, studies specifically targeting balance as a primary outcome in children with spastic diplegic CP remain limited, representing a clinically important gap that this study seeks to address.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
50
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: ibrahim A abu ella, Phd
- Telefonnummer: +201008442281
- E-mail: ibrahimneuron@gmail.com
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Confirmed diagnosis of spastic diplegic cerebral palsy by a paediatric neurologist or developmental paediatrician
- Age between 5 and 12 years
- Classified at GMFCS levels I-III
- Bilateral lower limb spasticity with a Modified Ashworth Scale (MAS) score of ≥ 1
Exclusion Criteria:
- Athetoid, ataxic, or mixed-type cerebral palsy
- GMFCS levels IV or V (non-ambulatory children)
- Uncontrolled seizure disorder or epilepsy not managed by medication
- Open wounds, skin infections, or active dermatological conditions contraindicating water immersion
- Fear of water (aquaphobia) or inability to tolerate the aquatic environment
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Study group
study group will receive aquatic exercise therapy
|
Aquatic therapy is a specialized rehabilitation approach that utilizes the physical properties of water, including buoyancy, hydrostatic pressure, and resistance, to facilitate movement and improve functional performance in children with diplegic cerebral palsy.
The aquatic environment reduces weight-bearing demands, allowing safer practice of balance, gait, strength, and motor control activities while minimizing joint stress.
Regular aquatic therapy may enhance muscle strength, postural stability, mobility, and overall participation in daily activities.
|
|
Aktiv komparator: control group
land exercise program
|
The control group participated in a conventional land-based exercise program consisting of stretching, strengthening, balance, and functional mobility exercises.
The program focused on improving lower-extremity muscle strength, postural control, gait performance, and overall functional abilities through activities performed on a stable surface.
Exercises were progressed according to each participant's abilities while maintaining consistency in treatment duration and frequency across the study groups.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
static balance
Tidsramme: baseline
|
Static and dynamic balance will be assessed using the Biodex Balance System.
Stability indices will be recorded to evaluate postural control and balance performance
|
baseline
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
25. juni 2026
Primær færdiggørelse (Anslået)
1. september 2026
Studieafslutning (Anslået)
15. september 2026
Datoer for studieregistrering
Først indsendt
20. juni 2026
Først indsendt, der opfyldte QC-kriterier
20. juni 2026
Først opslået (Faktiske)
25. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
25. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
20. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- trial CP
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
confidentiality of the research
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .